Drug Profile
Research programme: p53 function restorers - Xenova
Alternative Names: p53 function restorers research programme - XenovaLatest Information Update: 29 Jul 2004
Price :
$50
*
At a glance
- Originator Xenova Group
- Class Small molecules
- Mechanism of Action Tumour suppressor protein p53 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 29 Jul 2004 Discontinued - Preclinical for Cancer in United Kingdom (unspecified route)
- 03 Dec 1999 Preclinical development for Cancer in United Kingdom (Unknown route)